Reversible covalent direct thrombin inhibitors

INTRODUCTION: In recent years, the traditional treatments for thrombotic diseases, heparin and warfarin, are increasingly being replaced by novel oral anticoagulants offering convenient dosing regimens, more predictable anticoagulant responses, and less frequent monitoring. However, these drugs can...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivaraja, Mohanram, Pozzi, Nicola, Rienzo, Matthew, Lin, Kenneth, Shiau, Timothy P., Clemens, Daniel M., Igoudin, Lev, Zalicki, Piotr, Chang, Stephanie S., Estiarte, M. Angels, Short, Kevin M., Williams, David C., Datta, Anirban, Di Cera, Enrico, Kita, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072017/
https://www.ncbi.nlm.nih.gov/pubmed/30071045
http://dx.doi.org/10.1371/journal.pone.0201377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072017/
https://www.ncbi.nlm.nih.gov/pubmed/30071045
http://dx.doi.org/10.1371/journal.pone.0201377

Ejemplares similares